Literature DB >> 4583165

The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients.

G M Shenfield, M E Evans, S R Walker, J W Paterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4583165     DOI: 10.1164/arrd.1973.108.3.501

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  13 in total

1.  Comparison of two methods of administering bronchodilator aerosol to asthmatic patients.

Authors:  Y F Choo-Kang; I W Grant
Journal:  Br Med J       Date:  1975-04-19

2.  Letter: Exfoliative dermatitis during treatment with pheneturide.

Authors:  J W Rassam; G Anderson
Journal:  Br Med J       Date:  1975-04-19

3.  Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).

Authors:  P Worth Longest; Geng Tian; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2011-03-16       Impact factor: 2.849

4.  Aerosol salbutamol administration by IPPB: lowest effective dose.

Authors:  R E Ruffin; G Obminski; M T Newhouse
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

Review 5.  Antiasthmatic drugs. II. Therapeutic aspects.

Authors:  A S Rebuck
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Inhalation of beta-stimulants: dose-response relationship.

Authors:  U Wildbolz; H Bachofen; M Scherrer
Journal:  Lung       Date:  1978       Impact factor: 2.584

7.  Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma.

Authors:  P B Anderson; A Goude; M D Peake
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

8.  Management of severe acute asthma.

Authors: 
Journal:  Br Med J       Date:  1978-04-08

9.  The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol.

Authors:  G M Shenfield; M E Evans; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

Review 10.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.